- Home
- HOFT vs TARA Comparison
HOFT vs TARA Comparison
Compare HOFT & TARA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HOFT | TARA |
|---|---|---|
| Founded | 1924 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Home Furnishings | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 139.4M | 159.6M |
| IPO Year | 1999 | 2014 |
Fundamental Metrics
Financial Performance| Metric | HOFT | TARA |
|---|---|---|
| Price | $14.57 | $2.13 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 8 |
| Target Price | $16.50 | ★ $25.71 |
| AVG Volume (30 Days) | 26.2K | ★ 960.8K |
| Earning Date | 12-10-2026 | 11-17-2026 |
| Dividend Yield | ★ 2.98% | N/A |
| EPS Growth | N/A | ★ 38.25 |
| EPS | ★ 0.25 | N/A |
| Revenue | N/A | ★ $2,948,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $14.16 | N/A |
| P/E Ratio | $61.80 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $8.88 | $2.28 |
| 52 Week High | $18.09 | $7.82 |
Technical Indicators
Market Signals| Indicator | HOFT | TARA |
|---|---|---|
| Relative Strength Index (RSI) | 81.79 | 33.70 |
| Support Level | $15.08 | $2.28 |
| Resistance Level | $15.71 | $4.13 |
| Average True Range (ATR) | 0.49 | 0.15 |
| MACD | 0.32 | 0.04 |
| Stochastic Oscillator | 84.39 | 20.29 |
Price Performance
Historical ComparisonAbout HOFT Hooker Furnishings Corporation
Hooker Furnishings Corp is a designer, marketer, and importer of casegoods (wooden and metal furniture), leather furniture, fabric-upholstered furniture, lighting, accessories, and home decor for the residential, hospitality, and contract markets. It is also domestically manufactured premium residential custom leather, custom fabric-upholstered furniture, and outdoor furniture. The company operates in four segments: Hooker Branded segment, Domestic Upholstery segment, and All Other. It generates the majority of its revenue from the Hooker Branded segment.
About TARA Protara Therapeutics Inc.
Protara Therapeutics Inc is a clinical-stage biopharmaceutical company focused on advancing its therapies for the treatment of cancer and rare diseases. Its drug development pipeline includes: TARA-002, an investigational cell therapy in development for the treatment of non-muscle invasive bladder cancer (NMIBC) and lymphatic malformations (LMs); and IV Choline Chloride, an investigational phospholipid substrate replacement therapy, for patients receiving parenteral support, or PS, which includes both nutrition and fluids.